Imiglucerase 12522-7100-01
- Manufacturer
- Sanofi S.r.l.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- April 3, 2026
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imiglucerase | 40 U/mL |
Selected Package
12522-7100-01Selected100 VIAL, GLASS in 1 BOX (12522-7100-1) / 10 mL in 1 VIAL, GLASS (12522-7100-0)